Accelerate Diagnostics (NASDAQ: AXDX)
Accelerate Diagnostics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Accelerate Diagnostics Company Info
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
News & Analysis
This In Vitro Diagnostics Company Is Poised to Capture Its Share of a Growing Market
Recent news from Accelerate Diagnostics provides reason to believe the company can take market share in the global bloodstream-infection diagnostics market.
Up 6% in June, Is Accelerate Diagnostics a Good Buy Now?
Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly.
Accelerate Diagnostics Announces Emergency Use Authorization for Covid-19 Antibody Test
This new testing platform will speed up health checks by determining whether asymptomatic people have COVID-19 antibodies in 30 minutes.
2 Growing Healthcare Stocks You Should Know
Two of the sector's biggest winners of the past 10 years are still flying under the radar. Which looks like the better buy today?
The 10 Best Healthcare Stocks of the Decade
Which biotech was a 37-bagger?
Why Accelerate Diagnostics Inc Is Soaring Today
Shares jump after the FDA gives the green light to two of the company's products.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.